The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 15, 2024

Filed:

Nov. 10, 2021
Applicant:

Medregen, Llc, Baltimore, MD (US);

Inventors:

Zhaoli Sun, Baltimore, MD (US);

John Sun, Baltimore, MD (US);

Christy Eatmon, Greenville, NC (US);

Rachel Labell, Greenville, NC (US);

Zhimin Liu, Greenville, NC (US);

Richard Brewer, Greenville, NC (US);

Isaac Agyemang, Greenville, NC (US);

Mitchell Williams, Greenville, NC (US);

Assignee:

MedRegen, LLC, Baltimore, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/436 (2006.01); A61K 9/00 (2006.01); A61K 31/495 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/22 (2006.01); A61P 11/00 (2006.01); A61P 29/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/436 (2013.01); A61K 9/0019 (2013.01); A61K 31/495 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/22 (2013.01); A61P 11/00 (2018.01); A61P 29/00 (2018.01);
Abstract

Embodiments of the disclosure relate generally to formulations, methods, kits, and dosage forms for improved stability comprising at least two active ingredients, AMD3100, or similar stem cell mobilizer, and Tacrolimus, or FK506 derivative or analog, and one or more excipients. The formulations may be administered as a single dose subcutaneous injection. The formulations may be useful in treating various diseases, disorders or injuries.


Find Patent Forward Citations

Loading…